MyFinsight
Home
Blog
About
Contact
Back
Income Statement
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$159,559,000
(-254.13%↓ Y/Y)
Foreign currency
translation gain (loss)
$16,000
(77.78%↑ Y/Y)
Interest income, net
$5,800,000
(-41.20%↓ Y/Y)
Net loss
-$158,325,000
(-246.98%↓ Y/Y)
Unrealized loss on
securities
-$1,250,000
(-322.02%↓ Y/Y)
Total other income,
net
$5,800,000
(-41.06%↓ Y/Y)
Loss from operations
-$164,125,000
(-195.89%↓ Y/Y)
Total operating
expenses
$164,125,000
(195.89%↑ Y/Y)
Research and development
$150,150,000
(262.76%↑ Y/Y)
General and
administrative
$13,975,000
(-0.73%↓ Y/Y)
Back